T1	PROC 46 95	ENSAYO CLÍNICO ABIERTO, ALEATORIZADO Y CONTROLADO
T2	PROC 101 121	EVALUAR LA SEGURIDAD
T3	PROC 128 157	ADMINISTRACIÓN INTRABRONQUIAL
T4	Route 143 157	INTRABRONQUIAL
T5	ANAT 161 168	CÉLULAS
#1	AnnotatorNotes T5	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T6	DISO 173 192	ESTROMA MESENQUIMAL
T7	LIVB 207 216	PACIENTES
#2	AnnotatorNotes T7	C0030705; Patients; Patient or Disabled Group
T8	Neg_cue 221 228	RECHAZO
T9	Duration 229 236	CRÓNICO
T10	PROC 240 260	TRASPLANTE DE PULMÓN
#3	AnnotatorNotes T10	C0024128; Lung Transplantation; Therapeutic or Preventive Procedure
T11	Negated 240 260	TRASPLANTE DE PULMÓN
T12	LIVB 305 314	PACIENTES
#4	AnnotatorNotes T12	C0030705; Patients; Patient or Disabled Group
T13	Neg_cue 319 326	RECHAZO
T14	Duration 327 334	CRÓNICO
T15	PROC 338 358	TRASPLANTE DE PULMÓN
#5	AnnotatorNotes T15	C0024128; Lung Transplantation; Therapeutic or Preventive Procedure
T16	Negated 338 358	TRASPLANTE DE PULMÓN
T17	LIVB 392 401	pacientes
#6	AnnotatorNotes T17	C0030705; Patients; Patient or Disabled Group
T18	PROC 425 461	consentimiento informado por escrito
T19	LIVB 466 483	Pacientes adultos
T20	Age 476 483	adultos
T21	Age 484 492	≥18 años
T22	LIVB 536 545	Pacientes
#7	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	PROC 563 590	trasplante uni o bipulmonar
T24	PROC 594 605	Diagnóstico
#8	AnnotatorNotes T24	C0011900; Diagnosis; Diagnostic Procedure
T25	DISO 621 624	BOS
T26	PROC 631 635	FEV1
T27	PROC 645 648	FEF
T28	Neg_cue 674 677	sin
T29	Negated 678 688	otra causa
T30	Duration 711 730	los últimos 6 meses
T31	PROC 774 792	trasplante lobular
T32	PROC 809 839	trasplante de corazón y pulmón
T33	DISO 843 852	Infección
#9	AnnotatorNotes T33	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T34	Neg_cue 915 917	no
T35	PROC 918 925	tratado
T36	Negated 918 925	tratado
T37	Neg_cue 981 988	excepto
T38	DISO 989 1008	basocelular cutáneo
T39	Negated 989 1008	basocelular cutáneo
T40	DISO 1011 1028	carcinoma in situ
#10	AnnotatorNotes T40	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T41	Negated 1011 1028	carcinoma in situ
T42	DISO 1033 1068	Enfermedades autoinmunes sistémicas
T43	DISO 1073 1105	Infección activa por VIH/VHB/VHC
T44	PROC 1122 1131	serología
#11	AnnotatorNotes T44	C0036743; Serologic tests; Laboratory Procedure
T45	PROC 1134 1137	PCR
#12	AnnotatorNotes T45	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique | C0201657; C-reactive protein measurement; Laboratory Procedure
T46	DISO 1142 1176	Estenosis de la vía aérea proximal
T47	LIVB 1180 1199	Mujeres embarazadas
#13	AnnotatorNotes T47	C0033011; Pregnant Women; Population Group
T48	LIVB 1201 1208	mujeres
#14	AnnotatorNotes T48	C0043210; Woman; Population Group | C0242665; wife; Family Group
T49	PROC 1329 1345	Estado funcional
T50	DEVI 1368 1372	cama
T51	DEVI 1375 1380	silla
T52	PHYS 1418 1425	vigilia
#15	AnnotatorNotes T52	C0043012; Wakefulness; Mental Process
T53	PROC 1458 1469	actividades
T54	PROC 1473 1489	cuidado personal
T55	Duration 1518 1536	inferior a 3 meses
T56	DISO 1542 1559	Hipersensibilidad
#16	AnnotatorNotes T56	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T57	DISO 1618 1621	SCC
#17	AnnotatorNotes T57	C0206651; Clear Cell Sarcoma of Soft Tissue; Neoplastic Process
T58	LIVB 1680 1692	investigador
#18	AnnotatorNotes T58	C0035173; Research Personnel; Professional or Occupational Group
T59	LIVB 1722 1730	paciente
#19	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	PROC 1753 1767	ensayo clínico
#20	AnnotatorNotes T60	C0008976; Clinical Trials; Research Activity
